Trastuzumab Under Scrutiny: Is the Subcutaneous Hype Justified?
Explore the complexities surrounding trastuzumab, a standard treatment for HER-2 positive breast cancer. We investigate the benefits and economic impacts of its subcutaneous form, particularly in Central and Eastern European countries, where access and affordability are critical concerns.